Clark Estates Inc Eagle Pharmaceuticals, Inc. Transaction History

Clark Estates Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 13, 2019	SELL	$36.72 - $67.73 $2.07 Million - $3.81 Million	-56,278 Closed	0 $0
Q1 2018 Apr 18, 2018	BUY	$52.16 - $66.86 $2.94 Million - $3.76 Million	56,278 New	56,278 $2.97 Million

8.59M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $11.7M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

Stay updated on Clark Estates Inc with notifications on news.